2. Epigenetics
  3. Epigenetic Reader Domain
  4. BET-IN-13

BET-IN-13 is a potent BET inhibitor with an IC50 value of 1.6 nM. BET-IN-13 reduces LPS-induced TNF-α, IL-1β, IL-6, and NOS2 mRNA expression levels. BET-IN-13 shows anti-inflammatory activity. BET-IN-13 has the potential for the research of acute liver injury.

Para uso exclusivo en investigación. No vendemos a pacientes.

BET-IN-13

BET-IN-13 Estructura química

No. CAS : 2506823-08-9

Tamaño Stock
50 mg   Obtener un presupuesto  
100 mg   Obtener un presupuesto  
250 mg   Obtener un presupuesto  

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

BET-IN-13 Related Antibodies

Top Publications Citing Use of Products

  • Actividad biológica

  • Pureza y Documentación

  • Referencias

  • Revisión del cliente

Descripciòn

BET-IN-13 is a potent BET inhibitor with an IC50 value of 1.6 nM. BET-IN-13 reduces LPS-induced TNF-α, IL-1β, IL-6, and NOS2 mRNA expression levels. BET-IN-13 shows anti-inflammatory activity. BET-IN-13 has the potential for the research of acute liver injury[1].

IC50 & Target[1]

BRD4 BD1

57.4 nM (IC50)

BRD4 BD2

44.4 nM (IC50)

BRD2 BD1

79.3 nM (IC50)

BRD2 BD2

27.5 nM (IC50)

BRD3 BD1

45.6 nM (IC50)

BRD3 BD2

18.9 nM (IC50)

BRDT BD1

87.0 nM (IC50)

BRDT BD2

43.4 nM (IC50)

In Vitro

BET-IN-13 (compound 28) (1.1, 3.3, 10 µM, 2+6 h) reduces LPS (500 ng/ml) induced TNF-α, IL-1β, IL-6 and NOS2 mRNA expression levels in RAW264.7 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

BET-IN-13 Related Antibodies

RT-PCR[1]

Cell Line: RAW264.7 cells
Concentration: 1.1, 3.3, 10 µM
Incubation Time: Pre-treated for 2 h before stimulating with LPS for 6 h
Result: Significantly reduced LPS (500 ng/ml) induced TNF-α, IL-1β, IL-6 and NOS2 mRNA expression levels in a dose-dependent manner.
In Vivo

BET-IN-13 (3 mg/kg; i.v.; once) shows good pharmacokinetic (PK) properties with a T1/2 of 0.69 h, AUCINF-obs of 609 h*ng/mL and Vss of 1717 mL/kg in mouse[1].
BET-IN-13 (37.5, 75 mg/kg; i.p.; once) reduces the inflammation and hepatic damage without obvious toxicity in PS/D-GalN(d-gaiactosamine)-induced acute liver failure (ALF) mouse[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 20-22g, Female C57BL/6J mice (LPS/D-GalN(d-gaiactosamine)-induced acute liver failure (ALF))[1]
Dosage: 37.5, 75 mg/kg
Administration: I.p.; once
Result: Reduced inflammatory responses associated with LPS/GalN-induced acute liver failure with the survival rate increased significantly to 69.2% for37.5 mg/kg and to 84.6% for 75 mg/kg.
Peso molecular

497.56

Fòrmula

C28H23N3O4S
No. CAS
SMILES

CC1=C2C(NC=C3CN(C4=C(C(N32)=C1)C=C(C=C4)CS(C)(=O)=O)C(C5=CC=C6C=CC=CC6=C5)=O)=O
Envío

Room temperature in continental US; may vary elsewhere.
Almacenamiento

Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

BET-IN-13 Related Classifications

  • Calculadora de molaridad

  • Calculadora de dilución

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

BET-IN-132506823-08-9Epigenetic Reader DomainRAW264.7 cellsanti-inflammatoryLPSTNF-αacute liver injuryInhibitorinhibitorinhibit

Productos vistos recientemente:

Consulta en línea

Your information is safe with us. * Required Fields.

Nombre del producto

  

Requested Quantity *

Nombre del solicitante *

 

Saludo

Direcciòn del E-mail *

 

Número de teléfono *

Department

 

Nombre de la Organizaciòn *

City

Provincia

Country or Region *

      

Observaciones

Consulta para venta a granel

Inquiry Information

Nombre del producto:
BET-IN-13
Cat. No.:
HY-152213
Cantidad:
MCE Japan Authorized Agent:

Revisión del cliente

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Nombre del producto

  

Lot #

Nombre del solicitante *

 

Direcciòn del E-mail *

Número de teléfono

 

Department *

Nombre de la Organizaciòn *

 

Country or Region *

Observaciones

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.